Clinical Trial Update: Plasma exoRNA-Based Liquid Biopsy to Diagnose Clinically Significant Prostate Cancer

View source ↗

Summary

A clinical trial is evaluating a plasma exoRNA-based liquid biopsy to diagnose clinically significant prostate cancer and is currently recruiting at Xijing Hosp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Xijing Hospital | Conditions: Clinically Significant Prostate Cancer | Status: RECRUITING